Your session is about to expire
← Back to Search
Ablative Pre-operative Radiation for Early Stage Breast Cancer
Study Summary
This trial is testing how much radiation a person can handle before it becomes toxic. They will start with a low amount and work their way up to see how high they can go.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I agree to use birth control during and after the study if I can have children.I am a woman and at least 18 years old.I do not have any severe illnesses that would stop me from following the study's requirements.My scans show no cancer in the lymph nodes under my arm.My tumor does not affect the skin on top of it.I have had breast cancer in the same breast before.My cancer is located in one spot only.I am a woman who can still have children and have not been through menopause.Your tumor must be visible on a CT scan and may have a marker inside it.My breast cancer is 3 cm or less and hasn't been treated with surgery or drugs yet.My cancer is positive for estrogen or progesterone receptors and negative for HER2.I have had an MRI or a special mammogram to check the extent of my cancer.My tumor is very close to the skin, less than 5mm away.My tumor is larger than 3cm.I have had radiation therapy to the breast with cancer.My largest tumor is 3cm or smaller, measured before biopsy.I have active Lupus or scleroderma.My cancer is present in multiple locations.
- Group 1: Single-fraction stereotactic partial breast radiotherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA given clearance for Radiomics on MRI scans?
"Due to the limited amount of clinical data supporting its efficacy and safety, Radiomics on MRI is assigned a score of 1."
What is the participant base of this clinical research?
"Affirmative. Data hosted on clinicaltrials.gov demonstrates that this research experiment, which was initially posted on December 25th 2019 is currently recruiting for 70 participants at one medical site. Additionally, the post has been refreshed since August 25th 2022."
Can patients still participate in this experiment?
"Affirmative. Data from clinicaltrials.gov show that this trial is currently recruiting; it was first listed on December 25th of 2019 and the latest edit happened August 25th 2022. The study requires 70 participants to be recruited from 1 site in particular."
Share this study with friends
Copy Link
Messenger